• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Allergan

Allergan

Allergan PLC AGN

Last Price$217.48Day Change (%)-3.65%
Open Price$225.03Day Change ($)-8.24
Day Range216.02–225.8752-Week Range195.50–340.34

As of Tue 6/27/2016 8:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Mayne Pharma Buys US Drugs from Teva, Allergan for $652 Million

    Mayne Pharma Buys US Drugs from Teva, Allergan for $652 Million

  2. Millendo Therapeutics Appoints New Independent Board Member and Names Chairperson of the Board

    Millendo Therapeutics Appoints New Independent Board Member and Names Chairperson of the Board

  3. Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Allergan , Pfizer, ICStudy - Research and Markets

    Interstitial Cystitis (Painful Bladder Syndrome) Global Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Allergan , Pfizer, ICStudy - Research and Markets

  4. Sosei Appoints Peter Bains as CEO

    Sosei Appoints Peter Bains as CEO

  5. Lilly: German Supreme Court Grants Appeal in Dispute With Actavis

    Lilly: German Supreme Court Grants Appeal in Dispute With Actavis

  6. Dr. Reddy’s to acquire product portfolio from TEVA for US Market

    Dr. Reddy’s to acquire product portfolio from TEVA for US Market

  7. Business Watch -- WSJ

    Business Watch -- WSJ

  8. World Generic Markets Issue - More Work Necessary For WHO To Break Biosimilar Naming Stalemate - Research and Markets

    World Generic Markets Issue - More Work Necessary For WHO To Break Biosimilar Naming Stalemate - Research and Markets

  9. Dr. Reddy's Buying Eight Drugs From Teva for U.S. Market

    Dr. Reddy's Buying Eight Drugs From Teva for U.S. Market

  10. Allergan Defends Its Territory Against Increased Competition

    Brand recognition and product innovation keep the firm's moat wide.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.